Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Zebrafish xenotransplantation model for cancer stem-like cell study and high-throughput screening of inhibitors.

Zhang B, Shimada Y, Kuroyanagi J, Nishimura Y, Umemoto N, Nomoto T, Shintou T, Miyazaki T, Tanaka T.

Tumour Biol. 2014 Sep 11. [Epub ahead of print]

PMID:
25209178
[PubMed - as supplied by publisher]
2.

Identification of a novel indoline derivative for in vivo fluorescent imaging of blood-brain barrier disruption in animal models.

Nishimura Y, Yata K, Nomoto T, Ogiwara T, Watanabe K, Shintou T, Tsuboyama A, Okano M, Umemoto N, Zhang Z, Kawabata M, Zhang B, Kuroyanagi J, Shimada Y, Miyazaki T, Imamura T, Tomimoto H, Tanaka T.

ACS Chem Neurosci. 2013 Aug 21;4(8):1183-93. doi: 10.1021/cn400010t. Epub 2013 May 23.

PMID:
23668665
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The use of fluorescent indoline dyes for side population analysis.

Kohara H, Watanabe K, Shintou T, Nomoto T, Okano M, Shirai T, Miyazaki T, Tabata Y.

Biomaterials. 2013 Jan;34(4):1024-32. doi: 10.1016/j.biomaterials.2012.10.059. Epub 2012 Nov 9.

PMID:
23146431
[PubMed - indexed for MEDLINE]
4.

In vivo assessment of the permeability of the blood-brain barrier and blood-retinal barrier to fluorescent indoline derivatives in zebrafish.

Watanabe K, Nishimura Y, Nomoto T, Umemoto N, Zhang Z, Zhang B, Kuroyanagi J, Shimada Y, Shintou T, Okano M, Miyazaki T, Imamura T, Tanaka T.

BMC Neurosci. 2012 Aug 16;13:101. doi: 10.1186/1471-2202-13-101.

PMID:
22894547
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

In vivo imaging of zebrafish retinal cells using fluorescent coumarin derivatives.

Watanabe K, Nishimura Y, Oka T, Nomoto T, Kon T, Shintou T, Hirano M, Shimada Y, Umemoto N, Kuroyanagi J, Wang Z, Zhang Z, Nishimura N, Miyazaki T, Imamura T, Tanaka T.

BMC Neurosci. 2010 Sep 15;11:116. doi: 10.1186/1471-2202-11-116.

PMID:
20843315
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk